Home > News > Dog Virus Nanoparticles Adapted for Tumor Targeting
March 9th, 2006
Dog Virus Nanoparticles Adapted for Tumor Targeting
Abstract:
Writing in the Journal of Nanobiotechnology, a team led by Marianne Manchester, Ph.D., describes its studies aimed at determining whether mass-produced, non-infectious canine parvovirus nanoparticles might be suitable as a tumor-targeting drug delivery vehicle through the particles’ natural interaction with transferrin, a receptor that carries iron into cells. The reproducible size and chemical makeup of virus-based nanoparticles, combined with the relative ease of manufacturing them in large quantities, make them possible winners in the drive to develop nanoparticulate drug carriers for cancer therapy. Such laudable properties are only of use, however, if these protein nanoparticles can be modified to carry small molecules into tumor cells.
Source:
nano.cancer.gov
Bookmark:
| Related News Press |
Possible Futures
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||